<SEC-DOCUMENT>0001104659-21-016679-index.html : 20210209
<SEC-HEADER>0001104659-21-016679.hdr.sgml : 20210209
<ACCEPTANCE-DATETIME>20210209161646
ACCESSION NUMBER:		0001104659-21-016679
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20210205
FILED AS OF DATE:		20210209
DATE AS OF CHANGE:		20210209

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Juvenescence Ltd
		CENTRAL INDEX KEY:			0001724307
		STATE OF INCORPORATION:			Y8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38519
		FILM NUMBER:		21606598

	BUSINESS ADDRESS:	
		STREET 1:		18 ATHOL STREET
		CITY:			DOUGLAS
		STATE:			Y8
		ZIP:			IM1 1JA
		BUSINESS PHONE:		441624639396

	MAIL ADDRESS:	
		STREET 1:		18 ATHOL STREET
		CITY:			DOUGLAS
		STATE:			Y8
		ZIP:			IM1 1JA

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AgeX Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001708599
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				821436829
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		965 ATLANTIC AVENUE
		STREET 2:		SUITE 101
		CITY:			ALAMEDA
		STATE:			CA
		ZIP:			94501
		BUSINESS PHONE:		510-671-8370

	MAIL ADDRESS:	
		STREET 1:		965 ATLANTIC AVENUE
		STREET 2:		SUITE 101
		CITY:			ALAMEDA
		STATE:			CA
		ZIP:			94501
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>tm215727-1_4seq1.xml
<DESCRIPTION>OWNERSHIP DOCUMENT
<TEXT>
Document 1 - file: tm215727-1_4seq1.html

Document 1 - RAW XML: tm215727-1_4seq1.xml

</DOCUMENT>
</SEC-DOCUMENT>